Etoricoxib as a treatment of choice for patients with SLCO2A1 mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case report

por Albawa'neh, Areej, Al Mansoori, Mariam Ghareeb, Diab, Sehriban, Al Jasmi, Fatma, Akawi, Nadia
Publicado 2022